C07C 335/42
Sulfonylthioureas
Official title: Sulfonylthioureas; Sulfonylisothioureas
C07C335/42 (Sulfonylthioureas) appears on 34 US grants and 13 published applications in this corpus.
Search patents in C07C- Granted patents
- 34
- Published applications
- 13
- Assignees
- 16
- Inventors
- 62
- Latest grant
- 10 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 4 | 4 |
| 2003 | 2 | 0 |
| 2004 | 2 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds and compositions for treating conditions associated with NLRP activity10 Sep 2024US 12,084,424 B2Novartis AG
- Compounds and compositions for treating conditions associated with NLRP activity15 Aug 2023US 11,724,992 B2Novartis AG
- Compounds and compositions for treating conditions associated with NLRP activity21 Dec 2021US 11,203,579 B2Novartis AG
- Compounds and compositions for treating conditions associated with NLRP activity19 May 2020US 10,654,816 B2Novartis Inflammasome Research, Inc.
- Ubiquitin ligase inhibitors29 Mar 2011US 7,915,293 B2Rigel Pharmaceuticals, Inc.
- Compounds and compositions for treating conditions associated with nlrp activity16 Jul 2026US 2026/0200880 A1Novartis AG
- A facile and odor-free approach to convert sulfonyl urea derivatives to chalcogenide sulfonyl urea derivatives21 Aug 2025US 2025/0263367 A1The United States of America, as represented by the Secretary, Department of Health and Human Serice
- Sulfonamide derivatives and their use as soluble epoxide hydrolase inhibitors13 Feb 2025US 2025/0049736 A1
- Compounds and compositions for treating conditions associated with nlrp activity28 Dec 2023US 2023/0416211 A1Novartis AG
- Compounds and compositions for treating conditions associated with nlrp activity2 Mar 2023US 2023/0062815 A1Novartis AG
Most cited
By later US patents
- Ubiquitin ligase inhibitors41US 7,915,293 B2Rigel Pharmaceuticals, Inc. · 2011
- Lepidoptericidal isothiourea compounds19US 4,357,351 AStauffer Chemical Company · 1982
- Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them14US 6,511,989 B2Aventis Pharma Deutschland GmbH · 2003
- Urea and thiourea compounds useful for treatment of coccidiosis13US 6,875,764 B1New Pharma Research Sweden AB · 2005
- Lepidoptericidal isothiourea compounds12US 4,515,813 AStauffer Chemical Company · 1985